Alimera sciences (ALIM.US) reported revenue of $23.011 million in Q1 2024, up from $13.546 million in the previous quarter and expected revenue of $22.25 million. The EPS was -$0.12, compared to the previous quarter's -$0.71 and expected EPS of -$0.06.
Alimera Sciences(ALIM.US)：2024年Q1财报实现营收2301.1万美元，前值为1354.6万美元，预期值为2225万美元；每股收益为-0.12美元，前值为-0.71美元，预期值为-0.06美元。
Alimera Sciences (ALIM.US): The 2024 Q1 financial report achieved revenue of US$23.11 million, with a previous value of US$13.546 million and an expected value of US$22.25 million; earnings per share were -0.12 dollars, the previous value was -0.71 dollar
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.